Isla Leslie
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signaling.
Journal: Journal for immunotherapy of cancer
Published: February 07, 2026
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
Journal: International journal of cancer
Published: October 06, 2023
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade.
Journal: Journal for immunotherapy of cancer
Published: February 06, 2022
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Journal: Nature cancer
Published: December 24, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Journal: Research square
Published: September 28, 2021
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Journal: Nature cancer
Published: August 23, 2021
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Journal: Nature cancer
Published: August 18, 2021
On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: May 06, 2021
Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort Study.
Journal: Cancers
Published: February 08, 2021
Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective Analysis.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: August 16, 2020
Metastatic melanoma: therapeutic agents in preclinical and early clinical development.
Journal: Expert opinion on investigational drugs
Published: May 14, 2020
Avelumab and axitinib in the treatment of renal cell carcinoma: safety and efficacy.
Journal: Expert review of anticancer therapy
Published: April 16, 2020
Last Updated: 09/26/2026